Jiangsu Hansoh Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GEMCITABINE HYDROCHLORIDE USP, with a corresponding US DMF Number 31481.
Remarkably, this DMF maintains an Active status since its submission on March 24, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 11, 2017, and payment made on March 14, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II